Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CA 19-9' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 330 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Matsubayashi, H; Kuraoka, K; Kobayashi, Y; Yokota, T; Iiri, T; Shichijo, K; Tada, T; Satoh, K; Kijima, H
      Ruptured epidermoid cyst and haematoma of spleen: a diagnostic clue of high levels of serum carcinoembryonic antigen, carbohydrate antigen 19-9 and Sialyl Lewis x

      DIGESTIVE AND LIVER DISEASE
    2. Franchi, F; Pastore, C; Izzo, P; Calio, E
      Ca 19-9 in the monitoring of colorectal cancer after surgery

      MEDICAL ONCOLOGY
    3. Maass, N; Hojo, T; Ueding, M; Luttges, J; Kloppel, G; Jonat, W; Nagasaki, K
      Expression of the tumor suppressor gene maspin in human pancreatic cancers

      CLINICAL CANCER RESEARCH
    4. Akagi, J; Takai, E; Tamori, Y; Nakagawa, K; Ogawa, M
      CA19-9 epitope a possible marker for MUC-1/Y protein

      INTERNATIONAL JOURNAL OF ONCOLOGY
    5. Gaspar, MJ; Arribas, I; Coca, MC; Diez-Alonso, M
      Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma

      TUMOR BIOLOGY
    6. Zheng, CX; Zhan, WH; Zhao, JZ; Zheng, D; Wang, DP; He, YL; Zheng, ZQ
      The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer

      WORLD JOURNAL OF GASTROENTEROLOGY
    7. Jadvar, H; Fischman, AJ
      Evaluation of pancreatic carcinoma with FDG PET

      ABDOMINAL IMAGING
    8. Hanke, B; Riedel, C; Lampert, S; Happich, K; Martus, P; Parsch, H; Himmler, B; Hohenberger, W; Hahn, EG; Wein, A
      CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA)

      ANNALS OF ONCOLOGY
    9. Soudack, M; Ben-Nun, A; Toledano, C
      Elevated carbohydrate antigen 19-9 in patients with true (epithelial) splenic cysts - Rare or undiscovered?

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    10. Owono, P; Scoazec, JY; Valette, PJ; Dumortier, J; Gouysse, G; Berger, F; Boulez, J; Partensky, C
      Hepatobiliary cystic tumors. Clinical, radiological and histopathological study of 7 cases

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    11. Frena, A
      SPan-1 and exocrine pancreatic carcinoma. The clinical role of a new tumormarker

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    12. Forones, NM; Tanaka, M; Matos, D
      Relationship between mesenteric and peripheral blood levels of CA 19-9 in patients with colorectal cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    13. Tas, F; Aykan, F; Aydiner, A; Yasasever, V; Topuz, E
      Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    14. Yokoi, H; Nakata, M; Sawai, K; Yoshida, T; Koshikawa, M; Joyama, S; Tanaka, A; Goto, M; Ueda, S; Senzaki, H; Sugawara, A; Kuwahara, T
      Intraglomerular metastasis from pancreatic cancer

      AMERICAN JOURNAL OF KIDNEY DISEASES
    15. Nakagoe, T; Sawai, T; Tsuji, T; Ayabe, H; Nakazaki, T; Ishikawa, H; Hatano, K; Kajiwara, K; Miyashita, K; Matsuo, T; Nogawa, T; Arisawa, K
      Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer

      ANTICANCER RESEARCH
    16. Spila, A; Ferroni, P; Cosimelli, M; D'Alessandro, R; Abbolito, MR; Mariotti, S; Aloe, S; Carone, MD; Graziano, F; Tedesco, M; Martin, F; Mancini, R; Stigliano, V; Roselli, M; Guadagni, F
      Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation

      ANTICANCER RESEARCH
    17. Smorodin, EP; Kurtenkov, OA; Sergeyev, BL; Lilleorg, AL; Chuzmarov, VI
      Antibodies to tumor-associated carbohydrate epitopes in sera of cancer patients and blood donors

      EXPERIMENTAL ONCOLOGY
    18. Sreejayan, N; Wittig, BM; Von Stillfried, N; Hennicke, MS; Meyer, G; Stieber, P; Lamerz, R; Von Ritter, C
      Human biliary mucin binds to E-selectin: a possible role in modulation of inflammation

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    19. Ishigami, S; Natsugoe, S; Hokita, S; Che, XM; Tokuda, K; Nakajo, A; Iwashige, H; Tokushige, M; Watanabe, T; Takao, S; Aikou, T
      Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    20. Ohara, K; Tatsuzaki, H; Molotkova, NG; Oda, T; Yuzawa, K; Saida, Y; Matsuzaki, Y; Shimizu, W; Todoroki, T; Fukao, K; Tanaka, N; Itai, Y
      Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer

      HEPATO-GASTROENTEROLOGY
    21. Alatas, F; Alatas, O; Metintas, M; Colak, O; Harmanci, E; Demir, S
      Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions

      LUNG CANCER
    22. Heinemann, V
      Gemcitabine: Progress in the treatment of pancreatic cancer

      ONCOLOGY
    23. Kikuno, N; Urakami, S; Shigeno, K; Shiina, H; Igawa, M
      Urachal carcinoma associated with increased carbohydrate antigen 19-9 and carcinoembryonic antigen

      JOURNAL OF UROLOGY
    24. Marrelli, D; Pinto, E; De Stefano, A; De Manzoni, G; Farnetani, M; Garosi, L; Roviello, F
      Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer

      JOURNAL OF SURGICAL ONCOLOGY
    25. Duraker, N; Celik, AN
      The prognostic significance of preoperative sevum CA 19-9 in patients withresectable gastric carcinoma: Comparison with CEA

      JOURNAL OF SURGICAL ONCOLOGY
    26. Rumalla, A; Baron, TH; Wang, KK; Gores, GJ; Stadheim, LM; de Groen, PC
      Endoscopic application of photodynamic therapy for cholangiocarcinoma

      GASTROINTESTINAL ENDOSCOPY
    27. Ridwelski, K; Meyer, F; Fahlke, J; Kasper, U; Roessner, A; Lippert, H
      Value of cytokeratin and CA19-9 antigen in immunohistologic detection of disseminated tumor cells in lymph nodes from pancreatic carcinoma

      CHIRURG
    28. Ikeda, W; Okada, S; Tokuuye, K; Ueno, H; Okusaka, T
      Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy

      CANCER
    29. Dixon, E; Sutherland, FR; Mitchell, P; McKinnon, G; Nayak, V
      Cystadenomas of the fiver: a spectrum of disease

      CANADIAN JOURNAL OF SURGERY
    30. Marrelli, D; Pinto, E; De Stefano, A; Farnetani, M; Garosi, L; Roviello, F
      Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patientswith resectable gastric cancer

      AMERICAN JOURNAL OF SURGERY
    31. Marten, A; Schottker, B; Ziske, C; Weineck, S; Buttgereit, P; Huhn, D; Sauerbruch, T; Schmidt-Wolf, IGH
      Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein

      JOURNAL OF IMMUNOTHERAPY
    32. Nielsen, SE; Zeuthen, J; Lund, B; Persson, B; Alenfall, J; Hansen, HH
      Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma

      JOURNAL OF IMMUNOTHERAPY
    33. Ahmed, ASM; Long, M; Donaldson, D
      Lessons to be learned: a case study approach: Ascites and elevated serum CA 125 due to a pancreatic carcinoma. A diagnostic dilemma

      JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH
    34. Petaja, J; Pitkanen, S; Vettenranta, K; Fasth, A; Heikinheimo, M
      Serum tumor marker CA 125 is an early and sensitive indicator of veno-occlusive disease in children undergoing bone marrow transplantation

      CLINICAL CANCER RESEARCH
    35. Watanabe, M; Chigusa, M; Takahashi, H; Nakamura, J; Tanaka, H; Ohno, T
      High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    36. Goldstein, NS; Long, A; Kuan, SF; Hart, J
      Colon signet ring cell adenocarcinoma: Immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    37. Tabata, T; Takeshima, N; Tanaka, N; Hirai, Y; Hasumi, K
      Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma

      TUMOR BIOLOGY
    38. Lindhorst, E
      Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissueand in patients' sera during metastatic disease

      TUMOR BIOLOGY
    39. Urgell, E; Puig, P; Boadas, J; Capella, G; Queralto, JM; Boluda, R; Antonijuan, A; Farre, A; Lluis, F; Gonzalez-Sastre, F; Mora, J
      Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer

      EUROPEAN JOURNAL OF CANCER
    40. Kamoshida, S; Ogane, N; Yasuda, M; Muramatsu, T; Bessho, T; Kajiwara, H; Osamura, Y
      Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: The significance for papillary carcinomas

      MODERN PATHOLOGY
    41. Kajiume, T; Yoshimi, S; Kobayashi, K; Kataoka, N
      A case of malignant lymphoma in a patient with high levels of CA125 and CA19-9

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    42. Nozawa, F; Hirota, M; Okabe, A; Shibata, M; Iwamura, T; Haga, Y; Ogawa, M
      Tumor necrosis factor alpha acts on cultured human vascular endothelial cells to increase the adhesion of pancreatic cancer cells

      PANCREAS
    43. Tanaka, N; Okada, S; Ueno, H; Okusaka, T; Ikeda, M
      The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer

      PANCREAS
    44. Uno, K; Azuma, T; Nakajima, M; Yasuda, K; Hayakumo, T; Mukai, H; Sakai, T; Kawai, K
      Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    45. Barkin, JS; Goldstein, JA
      Diagnostic and therapeutic approach to pancreatic cancer

      BIOMEDICINE & PHARMACOTHERAPY
    46. Mann, DV; Edwards, R; Ho, S; Lau, WY; Glazer, G
      Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    47. Inamura, T; Nishio, S; Miyagi, Y; Kamikaseda, K; Ueda, K; Fukui, M; Yoshimoto, K
      Primary choroid plexus carcinoma producing carbohydrate antigen 19-9

      CLINICAL NEUROPATHOLOGY
    48. Giannini, E; Borro, P; Botta, F; Chiarbonello, B; Fasoli, A; Malfatti, F; Romagnoli, P; Testa, E; Risso, D; Lantieri, PB; Antonucci, A; Boccato, M; Milone, S; Testa, R
      Cholestasis is the main determinant of abnormal CA 19-9 levels in patientswith liver cirrhosis

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    49. Allende, MT; Vizoso, F; Suarez, C; Garcia, I; Sanz, L; Garcia-Muniz, JL; Roiz, C
      TAG-72 in gastric cancer: relationship between preoperative serum levels and tumoral content of the antigen

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    50. Behbehani, AI; Al-Sayer, H; Farghaly, M; Kanawati, N; Mathew, A; Al-Bader, A; Van Dalen, A
      Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    51. Thornthwaite, JT
      Anti-malignin antibody in serum and other tumor marker determinations in breast cancer

      CANCER LETTERS
    52. Opocher, E; Santambrogio, R; Bianchi, P; Cioffi, U; De Simone, M; Vellini, S; Montorsi, M
      Isolated splenic metastasis from gastric carcinoma - Value of CEA and CA 19-9 in early diagnosis: Report of two cases

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    53. Ahmed, S; Vaitkevicius, VK; Zalupski, MM; Du, W; Arlauskas, P; Gordon, C; Kellogg, C; Shields, AF
      Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma - A phase II study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    54. Brockmann, J; Emparan, C; Hernandez, CA; Sulkowski, U; Dietl, KH; Menzel, J; Wolters, H; Glodny, B; Senninger, N
      Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies

      ANTICANCER RESEARCH
    55. Makovitzky, J; Gotze, S
      Immunohistochemical investigation with carbohydrate monoclonal antibodies in cystic fibrosis

      ANTICANCER RESEARCH
    56. Reiter, W; Stieber, P; Reuter, C; Nagel, D; Lau-Werner, U; Lamerz, R
      Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer

      ANTICANCER RESEARCH
    57. Holubec, L; Topolcan, O; Pikner, R; Pecen, L; Vaclavickova, J; Wirthova, M; Molacek, J; Stieber, P; Holdenrieder, S; Sen, LH; Finek, J
      The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence

      ANTICANCER RESEARCH
    58. Martini, F; Guadagni, F; Lenti, L; D'Alessandro, R; Aloe, S; Roselli, M; Gazzaniga, PP; Ferroni, P
      CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation

      ANTICANCER RESEARCH
    59. Wietrzyk, J; Opolski, A; Madej, J; Laskowska, A; Radzikowski, C; Ugorski, M
      Metastatic potential of human uroepithelial cancer cells is not dependent on their adhesion to E-selectin

      ANTICANCER RESEARCH
    60. Okai, T; Kawashima, A; Watanabe, H; Takahashi, Y; Sakai, J; Ohtsubo, K; Motoo, Y; Matsui, O; Murakami, S; Nakabayashi, H; Sawabu, N
      Nonfunctioning islet cell carcinoma of the pancreas with high serum CEA & CA19-9, K-ras codon 12 mutation, and microsatellite instability

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    61. Marten, A; Ziske, C; Schottker, B; Renoth, S; Weineck, S; Buttgereit, P; Schakowski, F; Klingmuller, D; Scheffold, C; von Rucker, A; Sauerbruch, T; Schmidt-Wolf, IGH
      Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients

      INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
    62. Nozoe, T; Matsumata, T; Sugimachi, K
      Serum level of C-reactive protein may be a marker for proliferation of esophageal carcinoma

      HEPATO-GASTROENTEROLOGY
    63. Nazli, O; Bozdag, AD; Tansug, T; Kir, R; Kaymak, E
      The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma

      HEPATO-GASTROENTEROLOGY
    64. Wu, JT; Erickson, AJ; Tsao, KC; Wu, TL; Sun, CF
      Elevated serum chromogranin A is detectable in patients with carcinomas atadvanced disease stages

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    65. Ueno, H; Okada, S; Okusaka, T; Ikeda, M
      Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy

      ONCOLOGY
    66. Slesak, B; Harlozinska-Szmyrka, A; Knast, W; Sedlaczek, P; van Dalen, A; Einarsson, R
      Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis - A comparative study with CA 19-9

      CANCER
    67. Halm, U; Schumann, T; Schiefke, I; Witzigmann, H; Mossner, J; Keim, V
      Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survivaltime in patients with advanced pancreatic cancer

      BRITISH JOURNAL OF CANCER
    68. Patel, AH; Harnois, DM; Klee, GG; LaRusso, NF; Gores, GJ
      The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    69. Toki, T; Kubota, J; Lu, X; Nakayama, K
      Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    70. Tayyar, M; Tutus, A
      The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEA

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    71. Brockmann, J; Glodny, B; Menzel, J; Winde, G; Senninger, N
      Quantificating expression of tumormarkers in gallbladder bile for identification of malignancies of the subhepatic bilio-pancreatic system

      LANGENBECKS ARCHIVES OF SURGERY
    72. Kuroda, N; Hayashi, Y; Nishida, Y; Itoh, H
      Combined small and transitional cell carcinoma of the urinary bladder withCA19-9 production

      PATHOLOGY INTERNATIONAL
    73. Engaras, B; Hafstrom, L; Kewenter, J; Nilsson, O; Wedel, H
      Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA242 during twelve months in men and women aged 60-64 years without malignant disease

      EUROPEAN JOURNAL OF SURGERY
    74. Gaudagni, F
      The clinical utility of serum tumor markers in the management of gastrointestinal cancer patients

      JOURNAL OF CLINICAL LIGAND ASSAY
    75. Kau, SY; Shyr, YM; Su, CH; Wu, CW; Lui, WY
      Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    76. Kamoshida, S; Yasuda, M; Serizawa, A; Muramatsu, T; Shinozuka, T; Makino, T; Osamura, RY
      Immunohistochemical analysis of DU-PAN-2, CA9-9, and Le(a) in normal uterine glands

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    77. Nagele, H; Bahlo, M; Klapdor, R; Rodiger, W
      Tumor marker determination after orthotopic heart transplantation

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    78. van Dalen, A
      BR-MA, OM-MA, GI-MA and CEA: Clinical evaluation using the IMMULITE analyzer

      TUMOR BIOLOGY
    79. Sakamoto, Y; Yunotani, S; Edakuni, G; Mori, M; Iyama, A; Miyazaki, K
      Laparoscopic splenectomy for a giant splenic epidermoid cyst: Report of a case

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    80. van Leeuwen, DJ; Reeders, JWAJ
      Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma

      ANNALS OF ONCOLOGY
    81. Rhodes, JM
      Usefulness of novel tumour markers

      ANNALS OF ONCOLOGY
    82. Lamerz, R
      Role of tumour markers, cytogenetics

      ANNALS OF ONCOLOGY
    83. Barkin, JS; Goldstein, JA
      Diagnostic approach to pancreatic cancer

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    84. Yasasever, V; Oral, EN; Camlica, H; Dalay, N
      CA242 and total antioxidant levels in comparison to CEA and CA 19-9 in colorectal cancer

      JOURNAL OF TUMOR MARKER ONCOLOGY
    85. Lasch, K; Brasel, C; Jahn, H
      Selenium in therapy of colorectal cancer?

      MEDIZINISCHE KLINIK
    86. Cherchi, PL; Dessole, S; Ruiu, GA; Ambrosini, G; Farina, R; Capobianco, G; Ambrosini, A
      The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    87. Andicoechea, A; Vizoso, F; Alexandre, E; Martinez, A; Diez, MC; Riera, L; Martinez, E; Ruibal, A
      Comparative study of carbohydrate antigen 195 and carcinoembryonic antigenfor the diagnosis of pancreatic carcinoma

      WORLD JOURNAL OF SURGERY
    88. Plate, JMD; Shott, S; Harris, JE
      Immunoregulation in pancreatic cancer patients

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    89. Sakorafas, GH; Tsiotou, AG
      Pancreatic cancer in patients with chronic pancreatitis: a challenge from a surgical perspective

      CANCER TREATMENT REVIEWS
    90. Cappelli, G; Paladini, S; D'Agata, A
      Tumor markers in the diagnosis of pancreatic carcinoma

      TUMORI
    91. Erbagci, AB; Yilmaz, N; Kutlar, I
      Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA19-9, CA 125 and CA 15-3 in healthy women

      DISEASE MARKERS
    92. Makrantonakis, P; Pectasides, D; Aggouridakis, C; Visvikis, A; Daniilidis, J; Fountzilas, G
      Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck - A study of the Hellenic Co-Operative Oncology Group (HeCOG)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    93. Pedrazzoli, S; Pasquali, C; Sperti, C
      General aspects of surgical treatment of pancreatic cancer

      DIGESTIVE SURGERY
    94. Heinemann, V; Schermuly, MM; Stieber, P; Schulz, L; Jungst, D; Wilkowski, R; Schalhorn, A
      CA19-9: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin

      ANTICANCER RESEARCH
    95. Hasholzner, U; Stieber, P; Reiter, W; Zimmermann, A; Hofmann, K; Schalhorn, A
      CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer

      ANTICANCER RESEARCH
    96. Micke, O; Schafer, U; Willich, N
      Persistent elevation of CA 19-9 levels in a patient with an extended retroperitoneal dermoid

      ANTICANCER RESEARCH

    97. Tumour markers in gastrointestinal cancers - EGTM recommendations

      ANTICANCER RESEARCH
    98. Al-Sayer, H; Al-Bader, A; Hussein, T; Mathew, A; Behbehani, A; Dashti, H; Farghaly, M; Khorsheed, M; Van Dalen, A
      A prolife of tumor markers in the population of Kuwait

      ANTICANCER RESEARCH
    99. Spila, A; Ferroni, P; Cosimelli, M; D'Alessandro, R; Carone, MD; Aloe, S; Tedesco, M; Mancini, R; Casale, V; Carlini, S; Casciani, CU; Roselli, M; Guadagni, F
      Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer

      ANTICANCER RESEARCH
    100. Riker, A; Bartlett, D
      Pancreaticoduodenectomy for chronic pancreatitis: A case report and literature review

      HEPATO-GASTROENTEROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 07:25:30